Paul Jantzen

4.5k total citations · 2 hit papers
12 papers, 3.6k citations indexed

About

Paul Jantzen is a scholar working on Physiology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Paul Jantzen has authored 12 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Physiology, 5 papers in Cellular and Molecular Neuroscience and 5 papers in Neurology. Recurrent topics in Paul Jantzen's work include Alzheimer's disease research and treatments (10 papers), Neuroinflammation and Neurodegeneration Mechanisms (5 papers) and Cholinesterase and Neurodegenerative Diseases (4 papers). Paul Jantzen is often cited by papers focused on Alzheimer's disease research and treatments (10 papers), Neuroinflammation and Neurodegeneration Mechanisms (5 papers) and Cholinesterase and Neurodegenerative Diseases (4 papers). Paul Jantzen collaborates with scholars based in United States and Canada. Paul Jantzen's co-authors include Marcia N. Gordon, Dave Morgan, Karen Duff, Giovanni DiCarlo, John Hardy, Karen E. Connor, Leigh A. Holcomb, Donna M. Wilcock, David M. Diamond and Gary W. Arendash and has published in prestigious journals such as Nature, Nature Medicine and Journal of Neuroscience.

In The Last Decade

Paul Jantzen

11 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease

2000 1.2k citations Dave Morgan, David M. Diamond et al. Nature profile →
Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes

1998 1.1k citations Leigh A. Holcomb, Marcia N. Gordon et al. Nature Medicine profile →

Peers

Countries citing papers authored by Paul Jantzen

Since Specialization

Citations

This map shows the geographic impact of Paul Jantzen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Jantzen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Jantzen more than expected).

Fields of papers citing papers by Paul Jantzen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Jantzen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Jantzen. The network helps show where Paul Jantzen may publish in the future.

Co-authorship network of co-authors of Paul Jantzen

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Jantzen. A scholar is included among the top collaborators of Paul Jantzen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Jantzen. Paul Jantzen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	"Objects Worthy of Notice" Microscopical Anatomy of Selected Plants Collected by The Lewis & Clark Expedition 2005 ·Microscopy Today ·(unknown), (unknown), Kevin Ryan, Paul Jantzen, (unknown)	1
2	Increased Fibrillar β-Amyloid in Response to Human C1q Injections into Hippocampus and Cortex of APP+PS1 Transgenic Mice 2003 ·Neurochemical Research ·(unknown), Giovanni DiCarlo, Paul Jantzen, Jennifer Jackson, (unknown), Donna M. Wilcock, Dave Morgan, Marcia N. Gordon	28
3	The Association of Microglial Activation and Amyloid Reduction in APP+PS1 Transgenic Mice 2003 ·Dave Morgan, Paul Jantzen, Donna M. Wilcock, Giovanni DiCarlo, (unknown), Marcia N. Gordon	0
4	Time Course of the Development of Alzheimer-like Pathology in the Doubly Transgenic PS1+APP Mouse 2002 ·Experimental Neurology ·Marcia N. Gordon, Leigh A. Holcomb, Paul Jantzen, Giovanni DiCarlo, Donna M. Wilcock, (unknown), Karen E. Connor, (unknown), James P. O’Callaghan, Dave Morgan	206
5	Microglial Activation and β-Amyloid Deposit Reduction Caused by a Nitric Oxide-Releasing Nonsteroidal Anti-Inflammatory Drug in Amyloid Precursor Protein Plus Presenilin-1 Transgenic Mice 2002 ·Journal of Neuroscience ·Paul Jantzen, Karen E. Connor, Giovanni DiCarlo, Gary L. Wenk, John L. Wallace, Amyn M. Rojiani, Domenico Coppola, Dave Morgan, Marcia N. Gordon	289
6	Behavioral Assessment of Alzheimer's Transgenic Mice Following Long-Term A β Vaccination: Task Specificity and Correlations between A β Deposition and Spatial Memory 2001 ·DNA and Cell Biology ·Gary W. Arendash, Marcia N. Gordon, David M. Diamond, (unknown), Jaime M. Hatcher, Paul Jantzen, Giovanni DiCarlo, Donna M. Wilcock, Dave Morgan	100
7	Number of A β Inoculations in APP+PS1 Transgenic Mice Influences Antibody Titers, Microglial Activation, and Congophilic Plaque Levels 2001 ·DNA and Cell Biology ·Donna M. Wilcock, Marcia N. Gordon, Kenneth E. Ugen, Paul E. Gottschall, Giovanni DiCarlo, Chad A. Dickey, (unknown), Paul Jantzen, Karen E. Connor, (unknown), John Hardy, David Morgan	77
8	Correlation between cognitive deficits and Aβ deposits in transgenic APP+PS1 mice 2001 ·Neurobiology of Aging ·Marcia N. Gordon, David L King, David M. Diamond, Paul Jantzen, (unknown), Caroline E. Hope, Jaime M. Hatcher, Giovanni DiCarlo, (unknown), Dave Morgan, Gary W. Arendash	163
9	Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease breakdown → 2000 ·Nature ·Dave Morgan, David M. Diamond, Paul E. Gottschall, Kenneth E. Ugen, Chad A. Dickey, John Hardy, Karen Duff, Paul Jantzen, Giovanni DiCarlo, Donna M. Wilcock, Karen E. Connor, Jaime M. Hatcher, Caroline E. Hope, Marcia N. Gordon, Gary W. Arendash	1237
10	Behavioral Changes in Transgenic Mice Expressing Both Amyloid Precursor Protein and Presenilin-1 Mutations: Lack of Association with Amyloid Deposits 1999 ·Behavior Genetics ·Leigh A. Holcomb, Marcia N. Gordon, Paul Jantzen, Karen Hsiao, Karen Duff, Dave Morgan	288
11	Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes breakdown → 1998 ·Nature Medicine ·Leigh A. Holcomb, Marcia N. Gordon, Eileen McGowan, Xin Yu, (unknown), Paul Jantzen, Kristal Wright, (unknown), (unknown), Dave Morgan, (unknown), Cindy Zehr, (unknown), John Hardy, (unknown), Chris Eckman, Steve Younkin, Karen Hsiao, Karen Duff	1088
12	Endothelium-Dependent Vasorelaxation Caused by Various Plant Extracts 1995 ·Journal of Cardiovascular Pharmacology ·David F. Fitzpatrick, (unknown), (unknown), Paul Jantzen, Ronald G. Coffey	137

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact